2 weeks Ago By Defense World Staff
RxSight, Inc. ( NASDAQ:RXST – Get Free Report ) has been assigned a consensus rating of “Buy” from the eight analysts that are currently covering the stock, Marketbeat.com reports.
Eight investment analysts have rated the stock with a buy rating. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is $61.63.
A number of equities research analysts have recently issued reports on RXST shares. Jefferies Financial Group started coverage on shares of RxSight in a research note on Tuesday, October 29th. They issued a “buy” rating and a $72.
00 target price on the stock. Needham & Company LLC reaffirmed a “buy” rating and set a $66.00 target price on shares of RxSight in a report on Friday, September 13th.
Wells Fargo & Company lowered their price target on RxSight from $68.00 to $54.00 and set an “overweight” rating for the company in a report on Tuesday, August 6th.
Stifel Nicolaus dropped their price target on RxSight from $70.00 to $65.00 and set a “buy” rating on the stock in a research report on Tuesday, August 6th.
Finally, Oppenheimer decreased their price objective on shares of RxSight from $72.00 to $65.00 and set an “outperform” rating for the company in a report on Tuesday, August 6th.
Get Our Latest Stock Report on RxSight Insiders Place Their Bets Institutional Trading of RxSight Several hedge funds have recently added to or reduced their stakes in RXST. Vanguard Group Inc. increased its stake in RxSight by 2.
7% during the 1st quarter. Vanguard Group Inc. now owns 1,524,510 shares of the company’s stock valued at $78,634,000 after buying an additional 40,500 shares during the period.
Price T Rowe Associates Inc. MD raised its holdings in RxSight by 1.7% during the first quarter.
Price T Rowe Associates Inc. MD now owns 60,908 shares of the company’s stock worth $3,143,000 after purchasing an additional 994 shares in the last quarter. California State Teachers Retirement System lifted its position in RxSight by 6.
8% in the first quarter. California State Teachers Retirement System now owns 27,052 shares of the company’s stock worth $1,395,000 after purchasing an additional 1,733 shares during the period. RA Capital Management L.
P. boosted its stake in RxSight by 1.1% during the 1st quarter.
RA Capital Management L.P. now owns 3,442,825 shares of the company’s stock valued at $177,581,000 after purchasing an additional 38,540 shares in the last quarter.
Finally, CWM LLC raised its position in shares of RxSight by 727.5% during the second quarter. CWM LLC now owns 422 shares of the company’s stock worth $25,000 after purchasing an additional 371 shares during the period.
Institutional investors own 78.78% of the company’s stock. RxSight Trading Down 0.
7 % RXST stock opened at $46.06 on Wednesday. The company has a market capitalization of $1.
86 billion, a P/E ratio of -55.49 and a beta of 1.19.
The firm has a 50 day simple moving average of $49.20 and a 200-day simple moving average of $52.57.
RxSight has a twelve month low of $28.88 and a twelve month high of $66.54.
About RxSight ( Get Free Report RxSight, Inc, a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. Recommended Stories Five stocks we like better than RxSight Stock Market Sectors: What Are They and How Many Are There? Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story Why Warren Buffett Is Selling: A Look at His Latest Market Moves What Are the FAANG Stocks and Are They Good Investments? Why Amazon Shares May Never Trade Below $200 Again Receive News & Ratings for RxSight Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RxSight and related companies with MarketBeat.
com's FREE daily email newsletter ..
